Key result
Medical therapy including high-dose corticosteroids and methimazole led to complete recovery of cardiac function in a 32-month-old boy with Graves disease-induced dilated cardiomyopathy, with no cardiac relapse despite recurrent hyperthyroidism.
Case Report (n=1)
No
Medical therapy including early high-dose corticosteroids can successfully manage Graves disease-induced dilated cardiomyopathy in young children without requiring surgical resection or ablation.
Suggests medical therapy may restore function in rare pediatric Graves cardiomyopathy; leaves open corticosteroid benefit in prospective studies.
Graves disease (GD) can lead to complications such as cardiac arrhythmia and heart failure. Although dilated cardiomyopathy (DCMP) has been occasionally reported in adults with GD, it is rare in children. We present the case of a 32-month-old boy with DCMP due to GD. He presented with irritability, vomiting, and diarrhea. He also had a history of weight loss over the past few months. On physical examination, he had tachycardia without fever, a mild diffuse goiter, and hepatomegaly. The chest radiograph showed cardiomegaly with pulmonary edema, while the echocardiography revealed a dilated left ventricle with an ejection fraction (EF) of 28%. The thyroid function test (TFT) showed elevated serum T3 and decreased thyroid stimulating hormone (TSH) levels. The TSH receptor autoantibody titer was elevated. He was diagnosed with DCMP with GD; treatment with methylprednisolone, diuretics, inotropics, and methimazole was initiated. The EF improved after the TFT normalized. At follow-up several months later, although the TFT results again showed evidence of hyperthyroidism, his EF had not deteriorated. His cardiac function continues to remain normal 1.5 months after treatment was started, although he still has elevated T3 and high TSH receptor antibody titer levels due to poor compliance with drug therapy. To summarize, we report a young child with GD-induced DCMP who recovered completely with medical therapy and, even though the hyperthyroidism recurred several months later, there was no relapse of the DCMP.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2016) conducted a case report in Dilated cardiomyopathy with Graves disease (n=1). Medical therapy (methylprednisolone, methimazole, heart failure medications) was evaluated on Cardiac function recovery (Ejection fraction). Medical therapy including high-dose corticosteroids and methimazole led to complete recovery of cardiac function in a 32-month-old boy with Graves disease-induced dilated cardiomyopathy, with no cardiac relapse despite recurrent hyperthyroidism.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: